Some allege semaglutide, the active ingredient in Ozempic, may be linked to risks, including blood clots in the legs. This is in addition to the increased risk for people with Type 2 diabetes of plaque buildup in the arteries, which can lead to dangerous blood clots.
Ongoing studies will help determine the precise relationship between Ozempic and blood clots.